Sudarshan Pharma Industries Limited
Bookbuilding IPO · BSE
- Price band
- ₹71 - ₹73
- Lot size
- 1,600 shares
- Issue amount
- ₹50.1 cr
- Total subscription
- 1.06×
- Opens
- 9 Mar 2023
- Closes
- 14 Mar 2023
- Allotment
- 18 Mar 2023
- Listing
- 20 Mar 2023
Offer at a glance
Issue overview
- Issue size
- 68,62,400 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,13,600
- Fresh issue
- ₹50.1 cr
- Offer for sale
- ₹0 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,16,800
- Issue type
- Bookbuilding IPO
- Shares before issue
- 95,46,998
- Shares after issue
- 1,29,86,998
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,600 | ₹1,16,800 |
| HNI | 2 | 3,200 | ₹2,33,600 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Company information
Company profile
Incorporated in 2008, Sudarshan Pharma Industries Limited (SPIL) is a Mumbai-based company engaged in contract manufacturing, import, export, and supply of specialty chemicals, Active Pharmaceutical Ingredients (APIs), and intermediates. The company sources and supplies generic formulations by outsourcing manufacturing facilities from domestic and international suppliers based on client requirements. Its products find applications across industries such as pharmaceuticals, paints, food, and adhesives. SPIL also supplies medicines and pharma formulations to hospitals, NGOs, government bodies, and healthcare institutions under its own brand, offering around 50 formulations in tablets, capsules, ointments, and injectables. With a strong sales and distribution network across five states, the company markets its products ethically in both Indian and international markets, while also offering formulation development, quality control, and customized pharma solutions.
Strengths
- Customer-focused, order-driven model.
- Wide product portfolio.
- Contract manufacturing capabilities.
- Strong distribution & sales network.
- Diversified operations.
Promoters
Mr. Hemal Vasantrai Mehta
Mr. Sachin Vasantrai Mehta
Registrar & documents
Lead manager
Gretex Corporate Services Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
301,3rd Floor, Aura Biplex, Above Kalyan Jewellers S. V. Road, Borivali (West) Mumbai - 400092
022- 42221111
[email protected]Company website ↗Frequently Asked Questions
What is Sudarshan Pharma Industries IPO GMP today?
Currently, Sudarshan Pharma Industries IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹73. Track daily updates on IPO Premiums as bidding numbers unfold.
What is the lot size and minimum investment for Sudarshan Pharma Industries IPO?
The minimum bid lot size for Sudarshan Pharma Industries IPO is 1,600 shares. At the cut-off price of ₹73 per share, retail investors need a minimum application amount of ₹1,16,800 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Sudarshan Pharma Industries IPO allotment status be announced?
The allotment status for Sudarshan Pharma Industries IPO is scheduled to be finalized on 18 Mar 2023. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Kfin Technologies Limited's official portal or via BSE/NSE allotment portals.
How can I check Sudarshan Pharma Industries IPO allotment status online by PAN?
To check Sudarshan Pharma Industries IPO allotment status: 1) Visit the registrar portal (Kfin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Sudarshan Pharma Industries Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.